ALK and adenocarcinoma: Third, the ALK-positive cohort was probably enriched with patients with adenocarcinoma, as this mutation is nearly exclusively found in patients with this histology.15,33 The ALK-negative cohort, on the other hand, probably has heterogeneous histologic distribution (where about half are adenocarcinoma and a third are squamous cell carcinoma).